Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Releases from Bruker, Thermo Fisher, and More


Bruker last week introduced its benchtop Compact LC-QqTOF mass spectrometer.

The instrument features a 50 Gbit sample speed and 10 bit ADC detection technology and achieves sensitivity levels equivalent to triple quadrupoles while also delivering high-resolution full scan data on UHPLC timescales, the company said.

Thermo Fisher Scientific has released its new Dionex Ultimate 3000 Biocompatible Rapid Separation system designed for analysis of large molecules including peptides and proteins.

The company has also launched its new Chromeleon 7.2 software, which enables the integration of mass spectrometry and chromatography instruments on enterprise-wide networks.

Waters has released Quality Control Reference Materials and Certified Containers for evaluating and benchmarking LC and mass spec performance.

Bio-Rad has launched its Bio-Plex Pro RBM human, rat, and canine kidney toxicity panels.

The panels, developed in collaboration with Myriad RBM, consist of multiplexing immunoassays for measuring protein biomarkers for early detection and characterization of kidney toxicity and injury during drug development.

Phenomenex now offers its Kinetex Core-Shell media packed in its Axia hardware for HPLC and SFC.

The combination offers longer column lifetime, higher efficiencies, and improved performance and reproducibility compared to conventionally packed columns, the company said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.